The transcriptomic signature of myostatin inhibitory influence on the differentiation of mouse C2C12 myoblasts

Z Wicik1, T Sadkowski, M Jank

  • 1Department of Physiological Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Nowoursynowska 159, 02-776 Warsaw, Poland.

Insights

Growth differentiation factor 8 (GDF8), or myostatin, inhibits skeletal muscle cell growth and fusion. Global-transcriptome analysis revealed GDF8 regulates hundreds of genes involved in cell cycle and signaling pathways crucial for muscle development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genomics

Background:

  • Growth differentiation factor 8 (GDF8), also known as myostatin, is a key regulator of skeletal muscle mass.
  • Understanding myostatin's molecular mechanisms is crucial for developing therapies for muscle-wasting disorders.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which myostatin influences the differentiation of mouse C2C12 myoblasts.
  • To identify genes and signaling pathways affected by myostatin during myoblast differentiation.

Main Methods:

  • Global-transcriptome analysis using DNA microarray technique.
  • Treatment of mouse C2C12 myoblasts with exogenous GDF8.
  • Ontological analysis of gene expression data.

Main Results:

  • Exogenous GDF8 inhibited proliferation, differentiation, and cell fusion in C2C12 myoblasts.
  • DNA microarray analysis identified 778 genes regulated by GDF8 (436 down-regulated, 235 up-regulated).
  • GDF8 primarily disrupted cell cycle, calcium, and insulin signaling pathways, affecting cytoskeletal and muscle-specific protein expression.

Conclusions:

  • Myostatin significantly impacts skeletal muscle development by regulating a wide array of genes and signaling pathways.
  • Key genes such as Mef2, Hgf, Ilbl, Itgb1, Edn1, and Ppargc1a may act as myostatin targets in differentiating myoblasts.